Radiobiological effect of abdominal X-ray hypo-fraction irradiation on Wistar rats liver

Springer Science and Business Media LLC - Tập 11 - Trang 395-398 - 2012
Peng Qi1, Yongheng An1, Hongsheng Yu1, Xinjia He1
1Department of Oncology, The Affiliated Hospital of Qingdao University Medical College, Qingdao, China

Tóm tắt

The aim of our study was to investigate the impact of abdominal hypo-fraction irradiation on liver damage in rats so as to provide a reference for its clinical application. A total of 100 Wistar rats were equally randomized to five groups as control, 4 Gy, 6 Gy, 8 Gy and 12 Gy group, and the corresponding fractionated doses were offered. Liver functions were examined at the 2nd, 4th, 6th, 8th and 10th week after irradiation. Morphological changes were observed by HE staining. Expressions of Bcl-2 and Bax were examined by immunohistochemical technique. In all irradiation groups, hepatocellular swell, degeneration, necrosis and even hepatic fibrosis could be seen. The differences of the liver coefficient, Glutamyl pyruvic transaminase (GPT), Glutamyl oxaloacetic transaminase (GOT) were significant among the groups and different time points (F = 11.833–781.972, F = 20.857–264.692, P < 0.001). Expressions of Bcl-2 and Bax were significantly different between each group (F = 211.607, 116.577; P < 0. 001), and between each time point (F = 54.083, 68.749; P < 0. 001). Compare with conventional fraction, abdominal hypo-fraction irradiation may cause radiation damage to rat liver, being dose-and-time dependent. Up-regulation of activating apoptosis protein Bax and down-regulation of inhibiting apoptosis protein Bcl-2 may involve in the process.

Tài liệu tham khảo

Zhou XB, Ji XQ, Xu L. PPMS 1. 5 statistical software function and its application. ACTA Acad Med Qingdao Univ (Chinese), 2009, 45: 91–93. Chen GY. Hypo-fraction irradiation — the future of radiotherapy. Tumor, 2008, 28: 453–456. Fowler JF, Tome WA, Fenwick JD, et al. A challenge to traditional radiation oncology. Int J Radiat Oncol Biol Phys, 2004, 60:1241–1256. Yang RJ, Dai JR, Hu YM. Biological evaluation and optimization of Radiotherapy. Chin J Radiat Oncol (Chinese), 2006, 15: 172–175. Schneider U, Besserer J, Mack A. Hypofractionated radiotherapy has the potential for second cancer reduction. Theor Biol Med Model, 2010, 7: 4–10. Krishnan S, Dawson LA, Seong J, et al. Radiotherapy for hepatocellular carcinoma: an overview. Ann Surg Oncol, 2008, 15: 1015–1024. Mateen A, Javed AA, Masood AI. Concomitant chemoradiation using gemcitabine in locally advanced hepatocellular carcinoma. Chinese-German J Clin Oncol, 2012, 3: 130–133. Wang Dewen. Radiation injury pathomorphology. Wu Dechang editor. Radiation Medicine. Beijing: Military Medical Science Press, 2001. 104–105. Hua P, Liang J, Shi HJ, et al. An experimental study of dog liver injury and recovery after semi-liver alternate three-dimensional conformal and unconventional division radiotherapy. Mod Oncol (Chinese), 2006, 14: 270–272. Wang WD. Bcl-2/Bax ratio and the “life or death fate”. Chin J Cancer Biother (Chinese), 2007, 14: 393–396. Wang X, An YH, He XJ, et al. Impact of abdominal hypofractionation X2 ray irradiation on radiobiological effect in rat kidneys. Med J Qilu (Chinese), 2011, 26: 189–194.